关注公众号
收藏产品 产品详情
- Genetically modified cell lines best reflect MOA (Mechanism of Action)
- Higher activity and larger assay window for robust and reproducible cell-based bioassay
- Comprehensive application data to support assay development and validation
- Full tracible record, stringent quality control and validated cell passage stability
- Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
- Global commercial license assistance whenever regulatory filing is required
描述（Description）
CHO/Human GPRC5D Stable Cell Line
应用说明（Application）
• Binding assay by FACS and cell based ELISA.
生长特性（Growth Properties）
Suspension
筛选标记（Selection Marker）
MSX (20 μg/mL)
培养基（Complete Growth Medium）
OPM-CHO CDP3 medium (OPM, Cat. No. P081863-001)
冻存液（Freeze Medium）
10% DMSO + 90% FBS
装量（Quantity）
1 vial contains at least 5x10^6 cells in 1 ml of 10% DMSO in FBS.
存储（Storage）
Frozen in liquid nitrogen.
支原体检测（Mycoplasma Testing）
Negative
无菌检测（Sterility Testing）
Negative
使用说明（Instructions for Use）
See data sheet for detailed culturing and assay protocol.
产品展示
FACS Assay
FACS Analysis of CHO/Human GPRC5D Stable Cell Line.
FACS assay shows that Anti-GPRC5D antibody can bind to CHO/Human GPRC5D Stable Cell Line (Fig. B), and non-transfected CHO cells were used as a negative control (Fig. A). PE signal was used to evaluate the binding activity (QC tested).Protocol
Passage Stability
FACS Analysis cell passage stability of CHO/Human GPRC5D Stable Cell Line.
FACS assay shows that CHO/Human GPRC5D Stable Cell Line (Cat. No. CCHO-STP078) is stable after 15 times continuous passage.Protocol
用户评价 发表评论
背景介绍
前沿进展
Loading ...
药物研发进展 
联系我们 
项目合作